ImmunoCore

STRIVE: Soluble T-cell receptor intervention towards viral eradication

The STRIVE Study is looking at an investigational medication for patients with HIV infection who are currently on an antiretroviral therapy (ART) regimen. This study will look at how safe the study drug is and how the body handles taking the study drug and how the study drug affects the body’s immune system.

STRIVE logo.jpg